Summary

The Policy for maintenance pharmacotherapy for opioid dependence provides prescribers and pharmacists supplying pharmacotherapies with information about Victorian policy that regulates treatment of opioid dependence with pharmacotherapy (opioid replacement therapy). The policy advises practice standards for practitioners and aims to enhance coordination and cooperation between professionals involved in patient management. It also provides contacts for a range of support services

Summary of changes

The Summary of changes related to the use of long-acting injectable buprenorphine for opioid use dependence outlines the changes to the current Policy for maintenance pharmacotherapy for opioid dependence (for sublingual buprenorphine or buprenorphine/naloxone treatment) to include the requirements for using long-acting injectable buprenorphine.

Details

Publication Type
Document
Topic
Policies and guidelines
Date Published
04 Mar 2020
Size
Policy - 84 pages, Summary - 14
Update Frequency
Annual
Author
Department of Health & Human Services